The Neuropsychiatry of Multiple Sclerosis

Canadian Journal of Psychiatry

Volumn 49, Issue 3, 2004, Pages 157-163

  Feinstein, Anthony ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cognition; Mood; Multiple sclerosis; Neuroimaging; Translational research; Treatment

Indexed keywords

AMANTADINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BETA1A INTERFERON; CHOLINESTERASE INHIBITOR; DONEPEZIL; FLUOXETINE; GLATIRAMER; LEVODOPA; LITHIUM; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; OLANZAPINE; PLACEBO; QUETIAPINE; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

AFFECT; ALGORITHM; ANTICHOLINERGIC EFFECT; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BIPOLAR DISORDER; BRAIN FUNCTION; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CRYING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; EUPHORIA; FATIGUE; HUMAN; INFORMATION PROCESSING; MAJOR DEPRESSION; MEMORY DISORDER; MENTAL DISEASE; MENTAL HEALTH SERVICE; META ANALYSIS; MOOD DISORDER; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PHENOMENOLOGY; PRACTICE GUIDELINE; PREVALENCE; PSYCHOSIS; REVIEW; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; URINE INCONTINENCE;

EID: 1942505281     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370404900302     Document Type: Review

References (75)

1. Minden SL, Schiffer RB. Affective disorders in multiple sclerosis: review and recommendations for clinical research. Arch Neurol 1990;47:98-104.
2. Schubert RSB, Foliart RH. Increased depression in multiple sclerosis: a meta-analysis. Psychosomatics 1993;34:124-30.
3. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, and others. Lifetime and 12 month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Co-Morbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
4. Minden SL, Orav J, Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatry 1987;9:426-34.
5. Feinstein A. Multiple sclerosis and suicidal intent. Neurology 2002;59:674-8.
6. Sadovnik AD, Eisen RN, Ebers GC, Paty DW. Cause of death in patients attending multiple sclerosis clinics. Neurology 1991;41:1193-6.
7. Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z. Personal and family history of affective disorder in patients with multiple sclerosis. J Affect Disorders 1987;12:63-5.
8. Patten SB, Metz LM, Reimer MA. Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Multiple Sclerosis 2000;6:115-20.
9. Kroencke DC, Denney DR, Lynch SG. Depression during exacerbations in multiple sclerosis: the importance of uncertainty. Multiple Sclerosis 2001;7:237-42.
10. Dalos NP, Rabins PV, Brooks BR, O'Donnell P. Disease activity and emotional state in multiple sclerosis. Ann Neurol 1983;13:573-7.
11. Schiffer RB, Babigian HM. Behavioral disturbance in multiple sclerosis, temporal lobe epilepsy and amyotrophic lateral sclerosis: an epidemiologic study. Arch Neurol 1984;41:1067-9.
12. Reischies RG, Baum K, Brau H, Hedde JP, Schwindt G. Cerebral magnetic resonance imaging in multiple sclerosis. Relation to disturbance in affect, drive and cognition. Arch Neurol 1988;45:1114-6.
13. Sabatini U, Pozzilli C, Pantano P, Koudriavtseva T, Padovani A, Millefiorini E, and others. Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biol Psychiatry 1996;39:970-5.
14. Pujol J, Bello J, Deus J, Marti-Vilalta JL, Capdevila A. Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 1997;49:1105-10.
15. Bakshi R, Czarnecki D, Shaikh ZA, Priore RL, Janardhan V, Kaliszky Z, and others. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. NeuroReport 2000;11:1153-8.
16. Chamelian L, Feinstein A, Roy P, Lobaugh N, Feinstein K, O'Connor P, Black S. The relationship between multiple sclerosis and depression: a brain MRI segmentation study. J Neuropsychiatry Clin Neurosci 2003;15:260.
17. Lynch SG, Kroencke DC, Denney DR The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping and hope. Multiple Sclerosis 2001;7:4114-6.
18. The IFNB Multiple Sclerosis Study Group and the UBC MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-85.
19. Feinstein A, O'Connor P, Feinstein KJ. Multiple sclerosis, interferon beta-1b and depression: a prospective investigation. J Neurol 2002;249:815-20.
20. Patten SB, Metz L, for the SPECTRIMS Study Group. Interferon beta-1a and depression in secondary progressive MS: Data from the SPECTRIMS trial. Neurology 2002;59:744-6.
21. Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, and others. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicentre, double blind placebo controlled trial. Neurology 1995;45:1268-76.
22. Schiffer RB, Wineman M, Weitkamp LR. Association between bipolar affective disorder and multiple sclerosis. Am J Psychiatry 1986;143:94-5.
23. Minden SL, Orav J, Schildkraut JJ. Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology 1988;38:1631-4.
24. Schiffer RB, Weitkamp LR, Wineman NM, Guttormsen S. Multiple sclerosis and affective disorder: family history, sex and HLA-DR antigens. Arch Neurol 1988;45:1345-8.
25. Rabins PV. Euphoria in multiple sclerosis. In: Rao SM, editor. Neurobehavioral Aspects of Multiple Sclerosis. New York: Oxford University Press; 1990. p 180-5.
26. Feinstein A, Feinstein KJ, Gray T, O'Connor P. The prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Arch Neurol 1997;54:1116-21.
27. Feinstein A, O'Connor P, Gray T, Feinstein KJ. The pathogenesis of pathological laughing and crying in multiple sclerosis: a role for the prefrontal cortex? Multiple Sclerosis 1999;5:69-73.
28. Ironside R. Disorders of laughter due to brain lesions. Brain 1956;79:589-609.
29. Parvisi J, Anderson SW, Martin CO, Damasio H, Damasio AR. Pathological laughter and crying: a link to the cerebellum. Brain 2001;124:1708-19.
30. Damasio A. Looking for Spinoza. Joy, Sorrow and the Feeling Brain. Orlando (FL): Harcourt; 2003
31. Davison K, Bagley CR. Schizophrenia-like psychoses associated with organic disorders of the central nervous system. A review of the literature. In: Herrington RN, editor. Current problems in neuropsychiatry. Ashford, Kent (UK): Hedley; 1969. p 113-84.
32. Feinstein A, du Boulay G, Ron MA. Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. Br J Psychiatry 1992;161:680-5.
33. Schiffer RB, Wineman NM. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 1990;147:1493-7.
34. Flax JW, Gray J, Herbert J. Effects of fluoxetine on patients with multiple sclerosis. Am J Psychiatry 1991;148:1603.
35. Scott TF, Nussbaum P, McConnell H, Brill P. Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carrol Scale. Neurol Res 1995;17:421-2.
36. Barak Y, Ur E, Achiron A. Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open label trial. J Neuropsychiatry Clin Neurosci 1999;11:271-3.
37. Mattingley G, Baker K, Zorumski CF, Fiegel GS. Multiple sclerosis and ECT: possible value of gadolinium enhanced magnetic resonance scans for identifying high risk patients. J Neuropsychiatry Clin Neurosci 1992;4:145-51.
38. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 2001;69:942-9.
39. Mohr DC, Likosky W, Bertagnolli A, Goodkin DE, van der Wende J, Dwyer P, and others. Telephone-administered cognitive behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol 2000;68:356-61.
40. Schiffer RB, Herndon RM, Rudick RA. Treatment of pathologic laughter and weeping with amitriptyline. N Engl J Med 1983;312:1480-2.
41. Seliger GM, Hornstein A, Flax J, Herbert J, Schroder K. Fluoxetine improves emotional incontinence. Brain Injury 1992;6:267-70.
42. Udaka F, Yamao S, Nagata H, Nakamura S, Kameyama M. Pathologic laughing and crying treated with levodopa. Arch Neurol 1084;41:1095-6.
43. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
44. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns and prediction. Neurology 1991;41:685-91.
45. McIntosh-Michaelis SA, Wilkinson SM, Diamond ID, McLellan DL, Martin JP, Spackman AJ. The prevalence of cognitive impairment in a community survey of multiple sclerosis. Br J Clin Psychol 1991;30:333-48.
46. Rao SM. Neuropsychology of multiple sclerosis. A critical review. J Clin Exp Neuropsychol 1986;8:503-42.
47. Fisher J. Using the Wechsler Memory Scale - revised to detect and characterize memory deficits in multiple sclerosis. Clin Neuropsychol 1988;2:149-72.
48. Beatty WW, Goodkin DE, Monson N, Beatty PA, Hertsgaard D. Anterograde and retrograde memory amnesia in patients with chronic-progressive multiple sclerosis. Arch Neurol 1988;45:611-9.
49. Grant I, McDonald WI, Trimble MR, Smith E, Reed R. Deficient learning and memory in early and middle phases of multiple sclerosis. J Neurol Neurosurg Psychiatry 1984;47:250-5.
50. Wishart H, Sharpe D. Neuropsychological aspects of multiple sclerosis. J Clin Exp Neuropsychol 1997;19:810-24.
51. Beatty WW, Monson N. Metamemory in multiple sclerosis. J Clin Exp Neuropsychol 1991;13:309-27.
52. Grafman J, Rao S, Bernardin L, Leo GJ. Automatic memory processes in patients with multiple sclerosis. Arch Neurol 1991;48:1072-5.
53. Cummings JL. Subcortical dementia. Neuropsychology, neuropsychiatry and pathophysiology. Br J Psychiatry 1986;149:682-97.
54. Litvan I, Grafman J, Vendrell P, Martinez JM. Slowed information processing speed in multiple sclerosis. Arch Neurol 1988;45:281-5.
55. Beatty WW, Goodkin DE. Screening for cognitive impairment in multiple sclerosis. An examination of the mini-mental state examination. Arch Neurol 1990;47:297-301.
56. Kujala P, Portin R, Revonuso A, Ruutiainen J. Automatic and controlled information processing in multiple sclerosis. Brain 1994;117:1115-26.
57. Heaton RK, Nelson LM, Thompson DS, Burk JS, Franklin GM. Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol 1985;53:103-10.
58. Beatty WW, Monson N. Problem solving by patients with multiple sclerosis. Comparison of performance on the Wisconsin and California card sorting tests. J Int Neuropsychol Soc 1996;2:134-40.
59. Cummings JL. Frontal subcortical circuits and human behavior. Arch Neurol 1993;50:873-80.
60. Basso MR, Beason-Hazen S, Lynn J, Rammohan K, Bornstein RA. Screening for cognitive dysfunction in multiple sclerosis. Arch Neurol 1996;53:980-4.
61. Benedict RHB, Munschauer F, Linn R, Miller C, Murphy C, Foley F, and others. Screening for multiple sclerosis cognitive impairment using a self administered 15-item questionnaire. Multiple Sclerosis 2003;9:95-101.
62. Rao SM, Leo GJ, Haughton VM, St Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989;39:161-6.
63. Rao SM, Bernardin L, Ellington L, Ryan SB, Burg LS. Cerebral disconnection in multiple sclerosis. Relationship to atrophy of the corpus callosum. Arch Neurol 1989;46:918-20.
64. Arnett PA, Rao SM, Bernardin L, Grafman J, Yetkin FZ, Lobeck L. Relationship between frontal lobe lesions and Wisconsin Card Sort Test performance in patients with multiple sclerosis. Neurology 1994;44:420-5.
65. Filippi M, Tortorella C, Rovaris M, Bozzali M, Possa F, Sormani MP, and others. Changes in the normal appearing brain tissue and cognitive impairment in MS. J Neurol Neurosurg Psychiatry 2000;68:157-62.
66. Feinstein A, Youl B, Ron MA. Acute optic neuritis. A cognitive and magnetic resonance imaging study. Brain 1992;115:1403-15.
67. Hohol M, Guttmann CRG, Orav J, Mackin GA, Kikinins R, and others. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. Arch Neurol 1997;54:1018-25.
68. Rosewicz L, Langdon DW, Davie CA, Thompson A, Ron M. Resolution of left hemisphere cognitive dysfunction in multiple sclerosis with magnetic resonance correlates: a case report. Cognitive Neuropsychiatry 1996;1:17-25.
69. Sullivan MJL, Dehoux E, Buchanan DC. An approach to cognitive rehabilitation in multiple sclerosis. Canadian Journal of Rehabilitation 1989;4:99-105.
70. LaRocca N. Management of neurobehavioral dysfunction. A rehabilitation perspective. In: Rao SM, editor. Neurobehavioral Aspects of Multiple Sclerosis. New York: Oxford University Press; 1990. p 215-29.
71. Greene YM, Tariot PN, Wishart H, Cox C, Holt CJ, Schwid S, and others. A 12 week, open trial of donepezil hydrochloride in patients with multiple sclerosis associated cognitive impairments. J Clin Psychopharmacol 2000;20:350-6.
72. Fisher JS, Priore RL, Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, and others. Neuropsychological effects of interferon $-1b in relapsing-remitting multiple sclerosis. Ann Neurol 2000;48:885-92.
73. Weinstein A, Schwid SIL, Schiffer RB, McDermott MP, Giang DW, Goodman AD. Neuropsychological status in multiple sclerosis after treatment with glatiramer. Arch Neurol 1999;56:319-24.
74. Pliskin NH, Hamer DP, Goldstein MS, Towle VL, Reder AT, Noronha A, and others. Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon $-1b. Neurology 1996;47:1463-8.
75. Rao SM, Leo GJ, Ellington L, Nauertz T, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991;41:692-6.